Auxins Increase Post-transplant Growth of Vinca
نویسندگان
چکیده
منابع مشابه
Post-transplant hyperlipidaemia.
The correction of post-transplant hyperlipidaemia warrants the judicious and timely use of pharmacological agents with dietary modification and exercise. Reduction in hyperlipidaemia may have some role in decreasing the incidence of chronic rejection of allografts. The awareness that the morbidity and mortality of atherosclerotic disease may be lowered by active intervention will result in a be...
متن کاملPost-transplant lymphoproliferative disorder.
BACKGROUND Posttransplant lymphoproliferative disorder (PTLD) is increasingly recognized as a serious complication of solid organ transplantation in both children and adults. Factors associated with increased risk of PTLD include mismatch of recipient and donor EBV serologic status (seronegative recipient with seropositive donor), and intensive drug-induced immunosuppression. METHODS AND RESU...
متن کاملPost-transplant varicella infection.
Mr. M underwent renal transplant with mother as donor in 2007. He was started on Cyclosporin, Mycophenolate mofetil and steroids. One year post-transplant he presented with fever and generalized vesicular rash .The graft function was normal. He did not have any other systemic features. He gave a history of similar illness in his village. He did not suffer from chicken pox in his childhood. He d...
متن کاملPost-transplant Kaposi's sarcoma.
The once rare cancer called Kaposi’s sarcoma (KS) chiefly causes purple cutaneous niacules, plaques, or nodular infiltrates, although visceral involvement may occur without skin lesions, and primarily affects elderly men in the Mediterranean region and in Eastern Europe. Today, it is no longer a rare disease, and is in fact quite frequent in acquired immunodeficiency syndrome (AIDS) patients (I...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: HortScience
سال: 1997
ISSN: 0018-5345,2327-9834
DOI: 10.21273/hortsci.32.3.438a